Kohmann Bosshard Financial Services LLC Takes $31,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 59 shares of the medical equipment provider’s stock, valued at approximately $31,000.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Bennett Selby Investments LP lifted its stake in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares in the last quarter. Onefund LLC raised its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after acquiring an additional 18 shares in the last quarter. LVW Advisors LLC raised its stake in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. raised its stake in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC raised its stake in shares of Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after acquiring an additional 19 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 12,598 shares of company stock valued at $7,223,467. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $566.98 on Tuesday. The stock’s 50-day moving average is $570.66 and its two-hundred day moving average is $530.08. The firm has a market cap of $201.95 billion, a price-to-earnings ratio of 88.45, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on ISRG shares. Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Royal Bank of Canada increased their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Piper Sandler reissued an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.